findmyKOL

Donald Wallerson, MD

Basic profile

NewYork–Presbyterian Hospital

ORCIDNone on fileNPI
RegionBronx, NY · NortheastSpecialtyCardiovascular DiseaseFocusCardiology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2017Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Donald Wallerson is a Cardiology physician affiliated with NewYork–Presbyterian Hospital. OpenAlex indexes 37 publications with 1,347 citations (h-index 17).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
37publications

Distinct works indexed by OpenAlex.

1,347citations

Total citations across indexed works.

17h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
29companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

2310 Eastchester Rd
Bronx, NY 104695911

Telephone

718-519-6340

Registry record last updated 12 Jul 2012.

View the NPPES registry record

Industry payments

29 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    42.7%
    Beta blocker8.8%
    Metoprolol Succinate78%Carvedilol9%Atenolol6%Nebivolol Hcl5%Metoprolol Tartrate3%
    Part D<11 patients
    Angiotensin receptor blocker (ARB)7.8%
    Losartan Potassium46%Losartan-Hydrochlorothiazide41%Valsartan-Hydrochlorothiazide5%Valsartan5%Telmisartan3%
    Part D<11 patients

    + 13 more classes in this area

  • Metabolism & gastrointestinal

    23.9%
    Proton pump inhibitor6.1%
    Omeprazole82%Pantoprazole Sodium14%Esomeprazole Magnesium5%
    Part D<11 patients
    GLP-1 receptor agonist3.3%
    Ozempic80%Trulicity13%Wegovy7%
    Part D<11 patients

    + 11 more classes in this area

  • Nervous system

    9.1%
    Gabapentinoids3.9%
    Gabapentin87%Pregabalin13%
    Part D<11 patients
    gamma-Aminobutyric Acid A Receptor Positive Modulator1.2%
    Zolpidem Tartrate100%
    Part D18 patients

    + 8 more classes in this area

Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”